Ministério da Saúde
 
 
Advanced Search
 
Home / Registered Trials
All bellow

Title Primary Id Number RBR-3vmkt2
A Prospective Single Arm, Open-label, International, Multicenter Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Atazanavir (ATV) Powder Boosted with Ritonavir (RTV) Liquid with an Optimized NRTI Background Therapy, in HIV Infected Pediatric Patients Greater Than or Equal to 3 Months to Less Than 6 Years. (Pediatric Atazanavir International Clinical Evaluation: the PRINCE I study) Recruitment Status recruiting
Date of Registration June 13, 2011, 7:23 p.m.
Title Primary Id Number RBR-7sw5hf
LASER ACUPUNCTURE TO TEMPOROMANDIBULAR DISORDER TREATMENT Recruitment Status not yet recruiting
Date of Registration Feb. 2, 2011, 11:49 a.m.
Title Primary Id Number RBR-77q7t3
Evaluation of a new product to treatment of malaria in Brazil. Recruitment Status not yet recruiting
Date of Registration June 10, 2011, 11:48 a.m.
Title Primary Id Number RBR-4z7cnh
Facial edema reduction by manual lymphatic drainage at postoperative alveolar bone grafting. Recruitment Status recruitment completed
Date of Registration April 11, 2011, 9:40 p.m.
Title Primary Id Number RBR-7nq8m7
Steroid Therapy for Autistic Children Recruitment Status recruiting
Date of Registration April 12, 2011, 12:05 p.m.
Title Primary Id Number RBR-88btzp
Evaluation of the Implantation of an Anticoagulation Clinic in the Assistance of Chagas and Non-Chagas Patients at the Hospital of Clinics of the Universidade Federal de Minas Gerais - UFMG Recruitment Status recruitment completed
Date of Registration May 10, 2011, 7:20 p.m.
Title Primary Id Number RBR-36w269
A Randomized Double-Blind Phase 3 Trial Comparing Docetaxel Combined with Dasatinib to Docetaxel Combined with Placebo in Castration-Resistant Prostate Cancer Recruitment Status recruitment completed
Date of Registration June 13, 2011, 7:25 p.m.
Title Primary Id Number RBR-48pb9h
A Randomized Double-Blinded Phase II Study of Carboplatin/Paclitaxel/CT-322 versus Carboplatin/Paclitaxel/Bevacizumab as First-Line Treatment for Recurrent or Advanced Non-Small Cell Lung Cancer with Non-Squamous Histology Recruitment Status recruiting
Date of Registration June 13, 2011, 8:46 p.m.
Title Primary Id Number RBR-7spw98
A Phase III Open Label, Randomized, 2 Arm Study of Ixabepilone Administered Every 21 Days Versus Paclitaxel Or Doxorubicin Administered Every 21 Days in Women with Advanced Endometrial Cancer Who Have Previously Been Treated with Chemotherapy Recruitment Status recruiting
Date of Registration June 21, 2011, 3:02 p.m.
Title Primary Id Number RBR-9zxb97
Use of infrared laser in vaginal delivery Recruitment Status not yet recruiting
Date of Registration June 21, 2011, 3:09 p.m.
 
OpenTrials v1.2